Addus HomeCare Co. (NASDAQ:ADUS) Receives Average Recommendation of “Moderate Buy” from Brokerages

Addus HomeCare Co. (NASDAQ:ADUS) has earned an average rating of “Moderate Buy” from the seven brokerages that are presently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating and six have given a buy rating to the company. The average twelve-month price target among brokers that have covered the stock in the last year is $103.00.

A number of research analysts have commented on ADUS shares. Royal Bank of Canada restated an “outperform” rating and set a $102.00 price target on shares of Addus HomeCare in a research note on Thursday, February 29th. William Blair restated an “outperform” rating on shares of Addus HomeCare in a report on Monday, February 5th. Barclays lowered shares of Addus HomeCare from an “equal weight” rating to an “underweight” rating and set a $83.00 price target on the stock. in a research note on Tuesday. Finally, Oppenheimer reissued an “outperform” rating and issued a $118.00 price objective on shares of Addus HomeCare in a research note on Tuesday, March 26th.

Hedge Funds Weigh In On Addus HomeCare

A number of institutional investors and hedge funds have recently made changes to their positions in ADUS. AE Wealth Management LLC purchased a new stake in shares of Addus HomeCare during the 3rd quarter worth $469,000. SG Americas Securities LLC purchased a new stake in Addus HomeCare during the 3rd quarter worth about $532,000. Exchange Traded Concepts LLC acquired a new position in shares of Addus HomeCare during the 3rd quarter worth about $1,209,000. Sheets Smith Wealth Management increased its holdings in shares of Addus HomeCare by 2.5% in the 3rd quarter. Sheets Smith Wealth Management now owns 6,892 shares of the company’s stock valued at $587,000 after acquiring an additional 168 shares during the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in shares of Addus HomeCare by 19.7% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,278 shares of the company’s stock valued at $790,000 after acquiring an additional 1,528 shares during the last quarter. 95.35% of the stock is owned by institutional investors and hedge funds.

Addus HomeCare Stock Down 4.0 %

Shares of ADUS opened at $91.70 on Friday. The company has a current ratio of 1.38, a quick ratio of 1.38 and a debt-to-equity ratio of 0.18. The firm has a market cap of $1.49 billion, a P/E ratio of 23.88, a price-to-earnings-growth ratio of 1.87 and a beta of 0.96. The company’s 50-day moving average price is $97.73 and its 200 day moving average price is $91.59. Addus HomeCare has a 12-month low of $77.30 and a 12-month high of $114.97.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings results on Monday, February 26th. The company reported $1.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.04 by $0.17. The business had revenue of $276.35 million for the quarter, compared to the consensus estimate of $274.02 million. Addus HomeCare had a net margin of 5.91% and a return on equity of 9.70%. On average, sell-side analysts forecast that Addus HomeCare will post 4.38 earnings per share for the current year.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.